Mandate

Vinge has assisted Priveq in connection with the formation of Priveq Investment VII

June 04, 2024 Private Funds

Priveq, a leading Nordic lower mid-market growth and buyout investor, has closed its seventh fund, Priveq Investment VII, at SEK 3 billion. The fund’s first and final closing was significantly oversubscribed with strong backing from existing investors and substantial interest from new institutional investors.


The fund’s investor base consists of a diversified group of Nordic, European and North American investors including public and private pension funds, insurance companies, charitable foundations, endowments, public institutions, family offices and fund-of-funds.

Vinge has assisted Priveq as Swedish legal counsel in connection with the fund formation.

Vinge's team consisted of Mattias Schömer, Marcus Andersson, Nils Unckel, Anton Sjökvist, Emelie Svanberg, Tobias Onegård Karlsson, Semir Omerbasic, Emelie Zingmark, Helena Göransson, Nour Makie and Elias Kröger.

Related

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025

Vinge advises Karl Hedin and minority owners on the sale of AB Karl Hedin Sågverk to Vida

Vinge has advised Karl Hedin and minority shareholders in connection with the sale of AB Karl Hedin Sågverk to Vida Aktiebolag (“Vida”).
July 24, 2025